Tech Center 1600 • Art Units: 1621 1625 1634 1691
This examiner grants 77% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18030685 | PROCESS FOR RACEMIZING AND ISOLATING ATROPISOMERS OF 7-CHLORO-6-FLUORO-1-(2-ISOPROPYL-4-METHYLPYRIDIN-3-YL)PYRIDO[2,3-D]PYRIMIDINE-2,4(1H,3H)-DIONE | Non-Final OA | AMGEN INC. |
| 18566008 | COMPOSITIONS OF CLOFAZIMINE AND AMIKACIN FOR PULMONARY ADMINISTRATION IN THE TREATMENT OF RESPIRATORY DISEASES | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 17762325 | TREATMENT AND PREVENTION OF AGING RELATED-DISEASE AND/OR AGING BY THE INHIBITION OF SPHINGOLIPIDS | Non-Final OA | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) |
| 18629321 | SUBSTITUTED BENZIMIDAZOLES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | Non-Final OA | EPIGENETIX, INC. |
| 18615334 | METHODS AND COMPOUNDS FOR THE TREATMENT OR PREVENTION OF HYPERCYTOKINEMIA AND SEVERE INFLUENZA | Non-Final OA | Poolbeg Pharma (UK) Limited |
| 18596840 | METHODS OF TREATING PSYCHIATRIC DISORDERS IN OBESE PATIENTS WITH BREXPIPRAZOLE | Non-Final OA | Lake O'Hara LLC |
| 18514875 | METHODS FOR AMELIORATING AND PREVENTING AGE-RELATED MUSCLE DEGENERATION | Non-Final OA | NANJING NUTRABUILDING BIO-TECH CO., LTD. |
| 18419894 | ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF | Non-Final OA | Celgene Corporation |
| 18562768 | BIOMARKERS FOR AGE-RELATED MACULAR DEGENERATION | Non-Final OA | BELITE BIO, LLC |
| 18562676 | COMPOUNDS FOR DEGRADATION OF CYCLIN-DEPENDENT KINASE 7(CDK7) | Non-Final OA | QURIENT CO., LTD. |
| 18555467 | COCRYSTALLINE FORMS OF A BRUTON'S TYROSINE KINASE INHIBITOR | Non-Final OA | Loxo Oncology, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy